Synmosa Biopharma Corporation (TPEX: 4114)
Taiwan
· Delayed Price · Currency is TWD
36.85
-0.20 (-0.54%)
Oct 11, 2024, 1:30 PM CST
Synmosa Biopharma Revenue
Synmosa Biopharma had revenue of 1.33B TWD in the quarter ending June 30, 2024, with 1.65% growth. This brings the company's revenue in the last twelve months to 5.19B, up 5.17% year-over-year. In the year 2023, Synmosa Biopharma had annual revenue of 5.14B with 17.19% growth.
Revenue (ttm)
5.19B
Revenue Growth
+5.17%
P/S Ratio
2.99
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.45B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.14B | 754.13M | 17.19% |
Dec 31, 2022 | 4.39B | 1.15B | 35.59% |
Dec 31, 2021 | 3.23B | 196.67M | 6.47% |
Dec 31, 2020 | 3.04B | 358.32M | 13.37% |
Dec 31, 2019 | 2.68B | 316.77M | 13.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition